ABSTRACT
INTRODUCTION
Endometriosis and adenomyosis are defined by the presence of endometrial glands and stroma, located outside the uterus and in the myometrial wall, respectively 1 . The eutopic endometrium and the inner myometrium in patients affected by endometriosis and/or adenomyosis show several functional and structural abnormalities 1 . These differences seem to be related mainly to abnormal expression of genes involved in local estrogen production and response to progesterone, an altered oxidative stress response, and the presence of cytokines, inflammatory mediators and apoptotic markers 2, 3 . In the past 10 years, several studies have reported a correlation between endometriosis and major adverse obstetric outcomes, such as spontaneous late miscarriage 4 , preterm prelabor rupture of the membranes and preterm birth [5] [6] [7] [8] [9] [10] [11] , small-for-gestational age (SGA) 5, 10 , hypertension 9 , pre-eclampsia 5, 8, 11 , gestational diabetes 10 , obstetric hemorrhage (such as abruptio placentae and postpartum bleeding) 5, 9, 11 and placenta previa [5] [6] [7] 9, 12 . However, other studies 12, 13 and a systematic review 14 did not confirm completely the increased risk of obstetric complications in women with endometriosis. Theoretically, some pathogenic mechanisms might explain the higher risk of obstetric complications in women with endometriosis; these mechanisms include endometrial resistance to selective actions of progesterone, inflammation, inadequate uterine contractility, endometrial excessive activation of free radical metabolism and abnormal trophoblastic invasion into the 'myometrial junctional zone' due to partial or absent remodeling of the myometrial spiral arteries 15 . It is well known that there is a strong association between endometriosis and adenomyosis 16 . The reported prevalence of adenomyosis in patients affected by endometriosis ranges widely between 20% and 50% [17] [18] [19] and its association seems to be related to increasing age, parity, dysmenorrhea intensity and presence of deep infiltrating endometriosis (DIE) 20 . Previous studies also showed that women with adenomyosis are at increased risk of some adverse pregnancy outcomes, such as preterm delivery, preterm prelabor rupture of membrane, SGA and fetal malpresentation [21] [22] [23] . However, despite this background, previous studies have given little attention to the influence of adenomyosis on the pregnancy outcome of patients with endometriosis.
On the basis of these premises, the aim of the present study was to evaluate maternal and fetal outcomes in a cohort of women with endometriosis with or without the concomitant presence of diffuse or focal adenomyosis.
METHODS

Study design and study population
This study was based on a retrospective analysis of data collected prospectively between January 2014 and December 2016. The study protocol was approved by the regional ethics committee. Patients included in the study signed a general consent form for the use of their data for scientific purposes.
This study included pregnant women who had ultrasonographic and/or histological diagnosis of endometriosis with or without ultrasonographic diagnosis of focal or diffuse adenomyosis prior to conception. The ultrasonographic exams were performed at any phase of the menstrual cycle, regardless of the use of hormonal therapy. Standardized ultrasound criteria were used for the diagnoses of DIE 24 and endometriomas 25 . The ultrasonographic diagnosis of adenomyosis was made if two or more of the following features were present: asymmetrical myometrial thickening, myometrial cysts, linear striations, hyperechoic islands or an irregular and thickened endometrial-myometrial junctional zone on either two-or three-dimensional imaging 26, 27 . On ultrasonography, focal adenomyosis was defined as the presence of adenomyosis-related lesions in only one part of the myometrium, while diffuse adenomyosis was defined as the presence of ill-defined lesions in more than one site within the uterine wall, more often being dispersed within the myometrium rather than forming a confined lesion 28 . The patients included in the study were divided into three groups: those with endometriosis and focal adenomyosis, those with endometriosis and diffuse adenomyosis and those with endometriosis only.
Women with previous uterine surgery or uterine malformation, pregnancies with major fetal structural abnormality, chronic hypertension, known autoimmune disease or fetal aneuploidy, and multiple gestations were excluded.
Pregnancies were dated by measurement of crown-rump length in the first trimester according to the National Institute for Health and Care Excellence (NICE) guidelines 29 . Pregnancy-associated plasma protein-A (PAPP-A) levels were measured at the time of routine 11-14-week first-trimester combined screening test for Down syndrome. Uterine artery (UtA) Doppler indices were measured in all women at the 11-14-week examination and at the time of the routine anomaly scan between 19 and 23 weeks of gestation. UtA Doppler assessment was performed transabdominally 30 . The pulsatility index (PI) of the left and right UtAs was averaged to compute a mean PI and plotted against a published reference range 30 . All patients underwent a growth scan during the third trimester of pregnancy between 29 and 34 weeks of gestation to evaluate growth of the fetus. Low-dose aspirin for prevention of pre-eclampsia was not used during the study period. Ultrasound assessments were performed using a GE Voluson E6 ultrasound machine (GE Medical Systems, Zipf, Austria). Maternal characteristics, including age, body mass index (BMI), ethnic origin and mode of conception (spontaneous or in-vitro fertilization), were recorded during the first visit and pregnancy outcomes were collected. Delivery or follow-up scans were arranged as appropriate for any suboptimal assessments.
Gestational complications were defined as follows: preterm birth as delivery before 37 completed weeks of gestation; pregnancy-induced hypertension as blood pressure persistently over 140/90 mmHg that developed after 20 weeks of gestation in a previously normotensive woman; pre-eclampsia as gestational hypertension and proteinuria (> 300 mg/24 h); and SGA as birth weight < 10 th centile for gestational age.
Statistical analysis
Data distribution was assessed according to the Kolmogorov-Smirnov test of normality. Data were expressed as mean ± SD, or median and interquartile range. Categorical variables were described as number (% 30 . Mean UtA-PI was corrected for gestational age and multiples of the median were calculated based on reference ranges from the published centiles 30 . Logistic regression analysis was used to assess the associations of maternal characteristics, first-and second-trimester markers, and fetal outcome with SGA in women with endometriosis and diffuse adenomyosis and those with endometriosis and focal adenomyosis. P < 0.05 was considered statistically significant. Statistical analysis was performed using the statistical software package SPSS Statistics version 20.0 (IBM Corp., Armonk, NY, USA).
RESULTS
Demographic and pregnancy characteristics of the three groups of patients are presented in Tables 1 and 2 .
During the study period, 206 pregnant women with endometriosis were recruited into the study and completed the required follow-up. Among these patients, 148 (71.8%) had endometriosis only, 38 (18.4%) had focal adenomyosis and 20 (9.7%) had diffuse adenomyosis.
Compared with women with endometriosis only, those presenting with diffuse adenomyosis had significantly lower BMI and first-trimester PAPP-A level, and significantly higher first-trimester and mid-pregnancy mean UtA-PIs. The prevalence of a SGA fetus, calculated according to ultrasound-estimated fetal weight centile at the third-trimester ultrasound assessment, was significantly different between women with endometriosis only (10.8%) and those with diffuse adenomyosis (30%, P < 0.05). These results were confirmed after delivery, with the prevalence of SGA birth in women presenting with endometriosis only and that in women with diffuse adenomyosis being 10.8% (n = 16) and 40% (n = 8), respectively (P < 0.05). No statistically significant difference was found in 5-min Apgar score or in the prevalence of pre-eclampsia between the two groups of patients (Table 1) .
Compared with women with endometriosis only, those presenting with focal adenomyosis did not have significantly different maternal demographics, first-trimester PAPP-A level, first-trimester and mid-pregnancy mean UtA-PIs, estimated fetal weight centile or prevalence of SGA fetus. Moreover, no statistically significant difference was found in prevalence of SGA at birth, 5-min Apgar score or prevalence of pre-eclampsia between the two groups ( Table 1) .
Logistic regression analysis was used to assess the relationships of maternal and pregnancy characteristics with SGA at birth in those with diffuse adenomyosis and those with focal adenomyosis ( Table 2 ). The presence of diffuse adenomyosis was the only parameter associated independently with the delivery of a SGA infant.
DISCUSSION
Main findings
The study demonstrates that the presence of diffuse adenomyosis in pregnant women with endometriosis is associated with an increased risk of delivery of a SGA infant. When assessed in isolation, conventional risk factors for placental insufficiency, such as BMI, PAPP-A and mean UtA-PI during the first and second trimesters of pregnancy, showed a strong correlation with the presence of diffuse adenomyosis in patients with endometriosis. At the time of the third-trimester ultrasound assessment, the prevalence of a SGA fetus was significantly higher in the cohort of patients with diffuse adenomyosis compared with those with endometriosis only, and these data were confirmed after delivery. After adjusting the results for potential confounding variables, such as BMI and PAPP-A, logistic regression analysis demonstrated that only the presence of diffuse adenomyosis was associated with SGA at birth, while that of focal adenomyosis was not associated with delivery of a SGA infant.
The study results strongly suggest that, in women with endometriosis, diffuse adenomyosis increases the risk of having a SGA infant and they support a potential causative relationship between diffuse adenomyosis and impaired placentation and subsequent development of SGA.
Interpretation
In the past 10 years, research has been focused on the influence of endometriosis on pregnancy outcome [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [31] [32] [33] [34] . The data reported in the current literature are controversial and a systematic review concluded that there is no evidence that endometriosis has a major detrimental effect on pregnancy outcome 14 . However, the review found a correlation between endometriosis and placenta previa, with odds ratios ranging from 1.67 to 15.1 14 . In a recent retrospective case-control study including women with a singleton pregnancy conceived by in-vitro fertilization, Benaglia et al. found that women with endometriosis do not have an increased risk of preterm birth, hypertensive disorders, gestational diabetes, SGA or large-for-gestational-age newborns and neonatal problems 12 . In contrast, the authors confirmed that placenta previa was more common in women with endometriosis than in controls. Surprisingly, most published studies have not assessed the impact of adenomyosis on pregnancy outcome of patients with endometriosis. This is due to the fact that, in most of the studies, data were collected and analyzed retrospectively 7, 12, 13, 31, 33 , based on computerized national [4] [5] [6] 8, 11 or institutional 32 databases, or collected only at the time of delivery 10, 34 ; therefore, preconceptional ultrasonographic assessment of adenomyosis was not performed. Very recently, a cohort study found no significant difference in the incidence of complications during the pregnancy and delivery of patients with rectovaginal DIE in those with and those without an ultrasound diagnosis of adenomyosis 9 . However, in this study, Data are given as median (interquartile range), n (%) or mean ± SD. *Women with endometriosis and DA vs those with endometriosis only. †Women with endometriosis and FA vs those with endometriosis only. ART, assisted reproductive technologies; β-hCG, β-human chorionic gonadotropin; BMI, body mass index; EFW, estimated fetal weight; GA, gestational age; ICSI, intracytoplasmic sperm injection; IUI, intrauterine insemination; IVF, in-vitro fertilization; MoM, multiples of the median; PAPP-A, pregnancy-associated plasma protein-A; PI, pulsatility index; SGA, small-for-gestational age; US, ultrasound; UtA, uterine artery. the small sample size may have limited the strength of the analysis; in fact, only 30 patients with posterior DIE and adenomyosis were compared with 22 patients with posterior DIE without adenomyosis; furthermore, no subanalysis according to type of adenomyosis was performed 9 . Our study investigated, for the first time in the literature, the influence of diffuse and focal adenomyosis on adverse pregnancy outcome in a cohort of patients with endometriosis, revealing that the concomitant presence of diffuse adenomyosis in pregnant women with endometriosis is an important risk factor for placental insufficiency and consequent delivery of a SGA infant.
Adenomyosis seems to affect the process of junctional zone spiral artery remodeling from the onset of decidualization, and results in vascular resistance and increased risk of defective deep placentation 35 . Yorifuji et al. measured blood flow in the myometrium and placenta using time-slip magnetic resonance angiography in women with adenomyosis who had severe fetal growth restriction, and they found that the uterine adenomyosis area showed abundant blood flow while the placenta had diminished blood flow, suggesting that unbalanced perfusion of the placenta may be among the possible causes of SGA 36 . Furthermore, a case-control study in a cohort of 2138 pregnant women found that those with adenomyosis have a higher rate of preterm delivery and preterm prelabor rupture of membranes, probably due to increased local inflammatory response and higher levels of prostaglandins found in these patients 22 . More recently, a Japanese retrospective study based on the review of a computerized database compared the pregnancy outcome of 36 women diagnosed with adenomyosis before conception with that of 144 control women without uterine abnormality 23 . The authors found that women with adenomyosis have higher risks of preterm delivery, preterm prelabor rupture of membranes, SGA infant, fetal malpresentation and Cesarean delivery 23 . In agreement with these findings, another Japanese retrospective case-control study, including 49 singleton pregnancies complicated by adenomyosis and 245 controls, showed that patients with adenomyosis have increased risks of second-trimester miscarriage, pre-eclampsia, placental malposition and preterm delivery 21 .
Strengths and limitations
This study has some limitations. First, it is a retrospective study, although the data were collected prospectively. Second, the sample size was relatively small, especially in the subgroup analysis. The small number of pregnant women with endometriosis and adenomyosis did not allow further subanalysis to be performed according to the type of endometriosis diagnosed by ultrasonography (i.e. ovarian endometriomas or DIE). However, these preliminary findings may pave the way for future studies with a larger sample size. Finally, we did not exclude patients who conceived by assisted reproductive technology, and this could be a potential bias on the prevalence of adverse pregnancy outcome, such as pre-eclampsia, even though the number of these conceptions was quite small and similar between the study groups. The main strength of this study is that the subgroups of women with diffuse adenomyosis and those with focal adenomyosis were considered separately when compared with those with endometriosis only, allowing a clear understanding of the role of the different forms of adenomyosis in the development of adverse pregnancy outcome.
Conclusions
In conclusion, the current study shows that diffuse adenomyosis in pregnant women with endometriosis is strongly associated with delivery of a SGA infant. Women with endometriosis and diffuse adenomyosis should be treated as being at high risk of placental dysfunction and might need closer monitoring during pregnancy. These results are also potentially useful for preconception and prenatal counseling of women with both adenomyosis and endometriosis.
